Agent for preventing or improving symptoms caused by imbalance of sex hormones

a technology of sex hormone and agent, which is applied in the direction of drug composition, dispersed delivery, metabolic disorder, etc., can solve the problems of affecting work and daily life, affecting the onset of breast cancer, and causing ischemic cardiac disease, so as to prevent or improve symptoms, and prevent or improve symptoms.

Inactive Publication Date: 2017-11-09
MORINAGA MILK IND CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The inventor's agents are safe for use because they don’t harm other people who may have their own reproductive health issues such as menstrual irregularities like amenorrhea due to lack of estrogen during pregnancy. They also help improve sexual function when there aren′re certain types of women with low levels of testosterone that cause problems later on after childbirth.

Problems solved by technology

The technical problem addressed in this patents relates to finding effective drugs against women's reproductive health issues associated with reduced libidoception during menopause periods while avoiding negative effects related to decreased female endorscent bleeding time and amenorrheumatic diseases including infertilitas, vascular sores, pulmonary fibroses, chronoelastic bronchitis, etc., gastrointestinosis, renal impairment, heart attacks, strokes, orthodontic conditions, restless legs syndrome, erectile dystrophies, obstructives indigence, polypanosynthesis defiants, carboxylate synthesis products derived from plants, nutritional compositions, foodstuffs, medications, cosmeceuticals, antihypertensive agents, and others described in previous research publications.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Agent for preventing or improving symptoms caused by imbalance of sex hormones
  • Agent for preventing or improving symptoms caused by imbalance of sex hormones
  • Agent for preventing or improving symptoms caused by imbalance of sex hormones

Examples

Experimental program
Comparison scheme
Effect test

production example 1

(Production of Lophenol Compound (Compound 1))

[0138]Mesophyll of aloe vera (transparent gel portion) (100 kg) was liquefied using a homogenizer, and 100 L of an ethyl acetate / butanol (3:1) mixed liquid was added thereto, followed by stirring. After allowing to stand overnight, the ethyl acetate / butanol mixed liquid and an aqueous layer were separated to recover the ethyl acetate / butanol mixed liquid. This ethyl acetate / butanol mixed liquid was concentrated under reduced pressure. The mass of the recovered ethyl acetate / butanol mixed liquid extract was 13.5 g.

[0139]A solution obtained by dissolving 13 g of the extract in 1 ml of a chloroform / methanol (1:1) mixed liquid was passed through a column filled with 400 g of Silica Gel 60 (manufactured by Merck & Co., Inc.), the extract was adsorbed thereon, then, eluted by a stepwise gradient method of stepwisely increasing the methanol concentration using a chloroform / methanol mixed liquid (each mixing ratio of chloroform:methan

production example 2

(Production of Cyclolanostane Compound (Compound 2))

[0142]To 8.0 g of γ-oryzanol (manufactured by Oryza Oil & Fat Chemical Co., Ltd.) were added 250 ml of distilled water, 50 g of sodium hydroxide, 150 ml of isopropanol, 150 ml of ethanol, and 150 ml of methanol, and heating refluxing was performed for 2 hours using a mantle heater. After the reaction, the reaction liquid was added to 1300 ml of water, and the produced white precipitate was suction-filtered to obtain a solid. In order to wash the remaining alkali, the resulting residue was suspended in 1000 ml of water, and suction filtration was performed again. This operation was repeated two times, and the final residue was lyophilized under reduced pressure to obtain 5.91 g of an oryzanol hydrolysate. The hydrolysate was purified by HPLC to obtain 2435 mg of cycloartenol, and 1543 mg of 24-methylene-9,19-cyclolanostan-3-ol (Compound 2).

[0143]Then, using the resulting cycloartenol, 9,19-cyclolanostan-3-ol (Compound 2) was synthesize

production example 3

(Preparation of Sample Containing Mixture of Lophenol Compound and Cyclolanostane Compound Added Thereto)

[0145]Using 4-methylcholest-7-en-3-ol, 4-methylergost-7-en-3-ol and 4-methylstigmast-7-en-3-ol which had been obtained by Production Example 1, and 9,19-cyclolanostan-3-ol and 24-methylene-9,19-cyclolanostan-3-ol which had been obtained by Production Example 2, a mixture in which the mass ratio of the lophenol compound and the cyclolanostane compound was lophenol compound (Compound 1):cyclolanostane compound (Compound 2)=1:1 was obtained.

[0146]Using carboxymethylcellulose (CMC: manufactured by DKS Co., Ltd.), a mixture of the lophenol compound and the cyclolanostane compound was dispersed to prepare a 10000-fold diluted powder and a 100000-fold diluted powder. These powders were added to the AIN93G feed at 2%, to prepare a test sample 1 and a test sample 2.

[0147]That is, a test sample 1 containing Compound 1 (lophenol compound) and Compound 2 (cyclolanostane compound) at a total amo

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Provided is a means with which it is possible to efficiently prevent or improve symptoms caused by an imbalance of sex hormones with as little pain as possible, and which can safely be taken daily. A compound selected from the group consisting of a lophenol compound and a cyclolanostane compound is used as an active ingredient of an agent for preventing or improving symptoms caused by an imbalance of sex hormones.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner MORINAGA MILK IND CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products